KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Total Liabilities (2016 - 2025)

Pacira BioSciences (PCRX) has 16 years of Total Liabilities data on record, last reported at $571.8 million in Q4 2025.

  • For Q4 2025, Total Liabilities fell 26.23% year-over-year to $571.8 million; the TTM value through Dec 2025 reached $571.8 million, down 26.23%, while the annual FY2025 figure was $571.8 million, 26.23% down from the prior year.
  • Total Liabilities reached $571.8 million in Q4 2025 per PCRX's latest filing, roughly flat from $570.4 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $1.3 billion in Q4 2021 and bottomed at $570.4 million in Q3 2025.
  • Average Total Liabilities over 5 years is $795.0 million, with a median of $761.5 million recorded in 2023.
  • Peak YoY movement for Total Liabilities: surged 105.39% in 2021, then plummeted 36.09% in 2023.
  • A 5-year view of Total Liabilities shows it stood at $1.3 billion in 2021, then plummeted by 32.62% to $906.2 million in 2022, then fell by 22.28% to $704.3 million in 2023, then increased by 10.07% to $775.2 million in 2024, then fell by 26.23% to $571.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Liabilities were $571.8 million in Q4 2025, $570.4 million in Q3 2025, and $779.5 million in Q2 2025.